The HBeAb (Hepatitis B Envelope Antibody) Serum Test detects antibodies produced in response to the hepatitis B virus (HBV) envelope antigen. This test is used to monitor the progression of HBV infection and assess the body’s immune response. A positive HBeAb result may indicate a lower level of infectiousness and a reduced risk of virus transmission, as it typically signals the transition to the inactive phase of HBV infection. This test is essential for individuals diagnosed with hepatitis B, as it helps track infection status and determine the effectiveness of treatment.

The HBeAb Test is crucial for evaluating the progression and infectiousness of a hepatitis B infection. Detecting the presence of HBeAb antibodies typically indicates that the hepatitis B virus is in a less active or inactive state, reducing the likelihood of transmission. This test is often used for individuals undergoing hepatitis B treatment, as it aids in assessing treatment efficacy and monitoring the risk of liver-related complications. By providing insight into the infection's activity level, the HBeAb test supports effective management of hepatitis B and helps prevent the virus from progressing to more severe liver conditions.

Test price for other cities